Author:
Matthes Jan,Kollewe Katja
Publisher
Springer Berlin Heidelberg
Reference41 articles.
1. Bird S, Derry S, Moore RA (2014) Zolmitriptan for acute migraine attacks in adults. Cochrane Database Syst Rev 5:CD8616
2. van den Broek RW, Bhalla P, VanDenBrink AM, de Vries R, Sharma HS, Saxena PR (2002) Characterization of sumatriptan-induced contractions in human isolated blood vessels using selective 5-HT(1B) and 5-HT(1D) receptor antagonists and in situ hybridization. Cephalalgia 22:83–93
3. Deleu D, Hanssens Y (2000) Current and emerging second-generation triptans in acute migraine therapy: a comparative review. J Clin Pharmacol 40:687–700
4. Deng H, Li GG, Nie H, Feng YY, Guo GY, Guo WL, Tang ZP (2020) Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine – an updated systematic review and meta-analysis. BMC Neurol 20(1):57
5. Derry CJ, Derry S, Moore RA (2014) Sumatriptan (all routes of administration) for acute migraine attacks in adults – overview of Cochrane reviews. Cochrane Database Syst Rev 5:CD9108